Financhill
Back

Phreesia 10K Form

Sell
43

PHR
Phreesia

Last Price:
18.50
Seasonality Move:
32.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive PHR News And Ratings

See the #1 stock for the next 7 days that we like better than PHR

PHR Financial Statistics

Sales & Book Value

Annual Sales: $356.3M
Cash Flow: $3.66M
Price / Cash Flow: 0
Annual Sales: $4.36
Price / Book: 4.32

Profitability

EPS (TTM): -1.80000
Net Income (TTM): $-100.32M
Gross Margin: $232.29M
Return on Equity: -39.59%
Return on Assets: -27.57%

Phreesia Earnings Forecast

Key Phreesia Financial Ratios

  • The Gross Profit Margin over the past 7 years for PHR is 65.19%.
  • The Selling, General & Administrative Expenses for PHR have been equal to 63.69% of Gross Profit Margin.
  • The Research & Development expenses have been 31.53% of Revenue.
  • The Interest Expense is -1.35% of Operating Income.
  • The Net Earning history of PHR is -38.42% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Phreesia Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Technology
Sector: Health Care
Current Symbol: PHR
CUSIP: 71944F
Website: phreesia.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.77
Quick Ratio: 1.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 34.35

PHR Technical Analysis vs Fundamental Analysis

Sell
43
Phreesia (PHR) is a Sell

Is Phreesia a Buy or a Sell?

  • Phreesia stock is rated a Sell
    The current Phreesia [PHR] share price is $18.52. The Score for PHR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.